Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen® in Insulin Naive Subjects With Type 2 Diabetes

Mise à jour : Il y a 4 ans
Référence : NCT00600366

Femme et Homme

Extrait

This trial is conducted in Europe. The aim of this trial is to investigate the efficacy of biphasic insulin aspart 30 on blood glucose control in insulin naive type 2 diabetes failing on secondary oral hypoglycaemic agent (OHA).


Critère d'inclusion

  • diabetes ,Diabetes Mellitus, Type 2

Liens